The Meyerson research group focuses on fundamental studies nucleation, polymorphism, impurity-crystal interactions, novel separation methods, continuous crystallization, and industrial applications. In addition, the group actively participates in the Norvatis-MIT Center for Continuous Manufacturing.

Almost all of the products based on fine chemicals, such as dyes, explosives, and photographic materials require crystallization in their manufacture and over 90% of all pharmaceutical products contain bioactive drug substances and excipients in the crystalline solid state.

Crystallization is vital to many processes occurring in nature and manufacturing. In chemical, pharmaceutical, and food industries, crystallization from solution is widely used for a variety of materials.